FREE SHIPPING ON ORDERS OVER $150

foxo4-dri clinical trial humans Peptide Senolytic Peptide FOXO4-DRI Selectively Removes

$26.84

Quantity
- +
Description

Product Specifications CAS Number: 307297-39-8 Category: Peptides Subcategory: Longevity & Anti-Aging Peptides Peptide Sequence: Ala-Glu-Asp-Gly (AEDG) Chemical Formula: CHNO Molecular Weight: 390.34 g/mol Purity: 99% Packaging Format: 10 mg (lyophilized powder) Storage Conditions: Store at -20C

foxo4-dri clinical trial humans Peptide Senolytic Peptide FOXO4-DRI Selectively Removes

All peptides are synthesized in sterile, controlled environments to eliminate the risk of contamination and ensure batch consistency

foxo4-dri clinical trial humans Peptide Senolytic Peptide FOXO4-DRI Selectively Removes

Taking multiple medications that target the same hormonal pathways can sometimes amplify their effects

foxo4-dri clinical trial humans Peptide Senolytic Peptide FOXO4-DRI Selectively Removes

Advanced compound for enzymatic (NNMT) and metabolic pathway research

foxo4-dri clinical trial humans Peptide Senolytic Peptide FOXO4-DRI Selectively Removes

You may also like

recommand products